CAITLIN COLOSKY: Open Payments
NPI 1629439476 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 106 payments from 16 companies in 2025. Trend: 2023 $1,228 · 2024 $2,767 · 2025 $1,830
Food & beverage: $1,730Education: $100
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $330 |
| Galderma Laboratories, L.P. | 18 | $298 |
| PFIZER INC. | 19 | $194 |
| UCB, Inc. | 8 | $167 |
| ABBVIE INC. | 15 | $166 |
| Arcutis Biotherapeutics, Inc. | 10 | $158 |
| Novartis Pharmaceuticals Corporation | 4 | $129 |
| LEO Pharma Inc. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| GENZYME CORPORATION | 2 | $47 |
Products named: NEMLUVIO, CIBINQO, Bimzelx, ILUMYA, Zoryve, DUPIXENT, RINVOQ, ADBRY.
Industry payments across TX — which companies pay providers there.
